Xiidra Solution/ Drops
Product Images NDC 24208-911

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Xiidra (NDC 24208-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem (Image 01)

Chemical structure of Lifitegrast, the active ingredient in Xiidra 50 mg/mL ophthalmic solution, showing the detailed molecular arrangement including aromatic rings, chlorine atoms, amide groups, and a methylsulfonyl substituent.*

FDA Label Image

Take Foil (Image 02)

An instructional illustration showing hands opening a small sealed pouch, likely demonstrating how to open a single-use packet for an ophthalmic solution such as eye drops.*

FDA Label Image

Pull Single Vial (Image 03)

An illustration showing a hand holding one small single-use vial from a group of five vials lined up. The vials have a patterned label area and appear to be designed for individual dose dispensing, likely related to an ophthalmic solution.*

FDA Label Image

Put Remainder (Image 04)

Illustration of hands opening a foil pouch containing individual single-use vials of ophthalmic solution, likely representing dose preparation or administration steps for Xiidra (lifitegrast) ophthalmic solution 50 mg/mL.*

FDA Label Image

Fold Edge (Image 05)

An instructional illustration showing two hands opening a single-use packet, likely for administering an ophthalmic solution. The packet appears to be a small foil or plastic pouch, suitable for containing a dose of liquid drops, such as Xiidra ophthalmic solution.*

FDA Label Image

Hold (Image 06)

Illustration of a hand holding a single-use vial of ophthalmic solution, likely representing the Xiidra (Lifitegrast) 50 mg/mL ophthalmic drops. The vial has a small tab at the top for opening and a textured area for grip.*

FDA Label Image

Tap Top (Image 07)

An instructional line drawing showing hands holding a vial and a finger approaching the top of the vial, possibly illustrating how to open or activate the ophthalmic solution container.*

FDA Label Image

Open (Image 08)

An instructional illustration showing two hands opening a small vial, demonstrating the twisting motion needed to separate the vial's cap from the main body, likely for a single-use dose of ophthalmic solution.*

FDA Label Image

Eye (Image 09)

Illustration showing a person tilting their head back and using their fingers to apply eye drops into the eye, demonstrating the proper method of administering ophthalmic solution.*

FDA Label Image

Figure 1 (Image 10)

Four forest plots from studies comparing Xiidra (lifitegrast) versus vehicle. Each plot shows mean differences in outcomes with 95% confidence intervals at baseline and days 14, 42, and 84 visits, indicating effect size favoring Xiidra across time points in the four studies.*

FDA Label Image

Figure 2 (Image 11)

This figure presents four forest plots from separate studies comparing treatment effects between a vehicle and Xiidra (Lifitegrast ophthalmic solution 50 mg/mL) over multiple visits (Baseline, Day 14, Day 42, Day 84). Each plot shows mean differences with 95% confidence intervals and indicates if results favor Xiidra.*

FDA Label Image

Carton Label (Image 12)

Xiidra (lifitegrast ophthalmic solution) 5% carton label for a 60 single-use container package. The label indicates it is a 50 mg/mL ophthalmic solution by Bausch & Lomb Incorporated. The packaging includes dosage form, usage instructions, and a barcode on a white and blue background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.